{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:08Z","timestamp":1786119128484,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,19]]},"DOI":"10.1097\/qad.0b013e328303be16","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T13:04:12Z","timestamp":1236258252000},"page":"1226-1229","source":"Crossref","is-referenced-by-count":1,"title":["Liver ultrastructural morphology and mitochondrial DNA levels in HIV\/hepatitis C virus coinfection: no evidence of mitochondrial damage with highly active antiretroviral therapy"],"prefix":"10.1097","volume":"22","author":[{"given":"Motoi","family":"Matsukura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny FS","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Rietkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Farley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio S","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina C","family":"Montessori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne CF","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R2-17-20210130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/321819","article-title":"Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection","volume":"33","author":"Monga","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R3-17-20210130","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/hep.21722","article-title":"HIV and liver disease forum: conference proceedings","volume":"45","author":"Sherman","year":"2007","journal-title":"Hepatology"},{"key":"R4-17-20210130","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20626","article-title":"HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis","volume":"41","author":"Pineda","year":"2005","journal-title":"Hepatology"},{"key":"R5-17-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2893.2006.00816.x","article-title":"Therapeutic issues in HIV\/HCV-coinfected patients","volume":"14","author":"Sulkowski","year":"2007","journal-title":"J Viral Hepat"},{"key":"R6-17-20210130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2893.2006.00791.x","article-title":"Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)","volume":"14","author":"Rosenthal","year":"2007","journal-title":"J Viral Hepat"},{"key":"R7-17-20210130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"R8-17-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/COH.0b013e3281df3410","article-title":"Mechanisms of antiretroviral therapy-induced mitochondrial dysfunction","volume":"2","author":"Cote","year":"2007","journal-title":"Curr Opin HIV AIDS"},{"key":"R9-17-20210130","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/modpathol.3800652","article-title":"Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients","volume":"19","author":"Van Huyen","year":"2006","journal-title":"Mod Pathol"},{"key":"R10-17-20210130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00126334-200403010-00018","article-title":"Ultrastructural liver mitochondrial abnormalities in HIV\/HCV-coinfected patients receiving antiretroviral therapy","volume":"35","author":"Verucchi","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-17-20210130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"Cote","year":"2002","journal-title":"N Engl J Med"},{"key":"R12-17-20210130","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1086\/375353","article-title":"Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens","volume":"187","author":"Cote","year":"2003","journal-title":"J Infect Dis"},{"key":"R13-17-20210130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1699-0463.1988.tb05320.x","article-title":"Some new, simple and efficient stereological methods and their use in pathological research and diagnosis","volume":"96","author":"Gundersen","year":"1988","journal-title":"Apmis"},{"key":"R16-17-20210130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/jac\/dki392","article-title":"Chronic hepatitis C in patients with HIV\/AIDS: a new challenge in antiviral therapy","volume":"56","author":"Brau","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R17-17-20210130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0140-6736(00)03618-7","article-title":"Increased mitochondrial toxicity with ribavirin in HIV\/HCV coinfection","volume":"357","author":"Lafeuillade","year":"2001","journal-title":"Lancet"},{"key":"R18-17-20210130","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/00002030-200211080-00009","article-title":"Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors","volume":"16","author":"Walker","year":"2002","journal-title":"AIDS"},{"key":"R19-17-20210130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.20074","article-title":"Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine","volume":"39","author":"Walker","year":"2004","journal-title":"Hepatology"},{"key":"R20-17-20210130","first-page":"729","article-title":"Liver damage in HIV-infected patients","volume":"7","author":"Wnuk","year":"2001","journal-title":"Med Sci Monit"},{"issue":"Suppl 1","key":"R21-17-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-8278(97)82328-8","article-title":"Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation","volume":"26","author":"Fromenty","year":"1997","journal-title":"J Hepatol"},{"key":"R22-17-20210130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ncpendmet0505","article-title":"Nonalcoholic fatty liver disease: from pathogenesis to patient care","volume":"3","author":"Perlemuter","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R23-17-20210130","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2004.12.034","article-title":"An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation","volume":"42","author":"Abid","year":"2005","journal-title":"J Hepatol"},{"key":"R24-17-20210130","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the DAD study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200806190-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:38:20Z","timestamp":1786037900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200806190-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,19]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328303be16","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6,19]]}}}